New research into 3D printed medicine has shown – for the first time – that a combination of inkjet printing and UV curing can produce, “solid oral dosage forms” of drugs.
The research opens the door for personalized medicine, improvements in small scale clinical trials and “functionally graded dosage design.”
University of Nottingham scientists working with pharmaceutical company GlaxoSmithKline (GSK) conducted the study “3D Printing of Tablets Using Inkjet with UV Photoinitiation.”
